Remove tag
article thumbnail

RFID in Healthcare: Navigating Security & Privacy Regulations

Healthcare IT Today

RFID technology involves using tags and readers to wirelessly identify and track objects. Addressing Security and Privacy Concerns with RFID Regarding security and privacy concerns, one primary consideration is the information stored on RFID tags. FDA’s Drug Supply Chain Security Act (DSCSA).

HIPAA 85
article thumbnail

Telehealth and mail-order abortion possible in some states during pandemic

Healthcare IT News - Telehealth

Mifepristone, in combination with misoprostol, is FDA-approved for abortions up to ten weeks' gestation. And abortion's price tag isn't always covered by insurance, which could put it out of reach financially. Of course, the ruling doesn't remove all barriers to abortion via telemedicine.

COVID-19 175
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to win physician confidence in remote patient monitoring programs

Healthcare IT News - Telehealth

For reimbursement by the CMS, a device must be an FDA-listed device. However, an FDA approval ensures a medical device is safe and effective for its intended use. FDA classifies medical devices into three classes based on risk to human life. Dr. Joyoti Goswami is a Principal Consultant at Damo Consulting.

article thumbnail

Health Provider News

Hall Render

Inman College of Nursing FDA clears Collierville startup CircumFix’s medical device for surgery, marketing FTC opposes Novant Health’s $320M hospital deal with Community Health Systems HCA CFO to retire HCA nets $5.2B

article thumbnail

Health Provider News

Hall Render

Nevada Medicaid must cover abortion services, judge rules Clark County health rankings improve, but physicians per capita still well below U.S.

article thumbnail

Third Circuit Tosses Criminal Charge that Unauthorized Ingredient Source was Introduction of a “New Drug” 

Drug & Device Law

July 20, 2023), was decidedly unpleasant for the government – specifically, the Food and Drug Administration. The government prosecuted a drug company and its executives for sourcing an active ingredient from a facility not included in the drug approvals, and for lying about it. The company was also tagged with a count of mail fraud.

FDA 52